Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease

W Zhou, M Kanai, KHH Wu, H Rasheed, K Tsuo… - Cell Genomics, 2022 - cell.com
Biobanks facilitate genome-wide association studies (GWASs), which have mapped
genomic loci across a range of human diseases and traits. However, most biobanks are …

Mechanisms of sarcomere protein mutation-induced cardiomyopathies

DY Barefield, A Alvarez-Arce, KN Araujo - Current cardiology reports, 2023 - Springer
Abstract Purpose of Review The pace of identifying cardiomyopathy-associated mutations
and advances in our understanding of sarcomere function that underlies many …

Assessing Cardiac Contractility From Single Molecules to Whole Hearts

A Garg, KJ Lavine, MJ Greenberg - Basic to Translational Science, 2024 - jacc.org
Fundamentally, the heart needs to generate sufficient force and power output to dynamically
meet the needs of the body. Cardiomyocytes contain specialized structures referred to as …

A human hereditary cardiomyopathy shares a genetic substrate with bicuspid aortic valve

M Siguero-Álvarez, A Salguero-Jiménez… - Circulation, 2023 - Am Heart Assoc
Background: The complex genetics underlying human cardiac disease is evidenced by its
heterogenous manifestation, multigenic basis, and sporadic occurrence. These features …

Opposing effects of genetic variation in MTCH2 for obesity versus heart failure

JA Fischer, TO Monroe, LL Pesce… - Human molecular …, 2023 - academic.oup.com
Genetic variation in genes regulating metabolism may be advantageous in some settings
but not others. The non-failing adult heart relies heavily on fatty acids as a fuel substrate and …

Functional assays reveal the pathogenic mechanism of a de novo tropomyosin variant identified in patient with dilated cardiomyopathy

SK Barrick, A Garg, L Greenberg, S Zhang… - Journal of Molecular and …, 2023 - Elsevier
Dilated cardiomyopathy (DCM) is a leading cause of heart failure and a major indicator for
heart transplant. Human genetic studies have identified over a thousand causal mutations …

[HTML][HTML] Personalized transcriptome signatures in a cardiomyopathy stem cell biobank

E Monte, T Furihata, G Wang, I Perea-Gil, E Wei… - bioRxiv, 2024 - ncbi.nlm.nih.gov
BACKGROUND: There is growing evidence that pathogenic mutations do not fully explain
hypertrophic (HCM) or dilated (DCM) cardiomyopathy phenotypes. We hypothesized that if a …

Phenotyping heart failure by genetics and associated conditions

J Wong, S Peters, TH Marwick - European Heart Journal …, 2023 - academic.oup.com
Heart failure is a highly heterogeneous disease, and genetic testing may allow phenotypic
distinctions that are incremental to those obtainable from imaging. Advances in genetic …

[HTML][HTML] Фенотипическая вариабельность гипертрофической кардиомиопатии у носителей патогенного варианта p. Arg870His гена MYH7

АН Кучер, НР Валиахметов, РР Салахов… - Бюллетень …, 2022 - cyberleninka.ru
Обзор посвящен анализу вариабельности клинических проявлений неоднократно
зарегистрированного у пациентов с гипертрофической кардиомиопатией (ГКМП) …

The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum

S Mukhopadhyay, P Dixit, N Khanom… - Journal of …, 2024 - Springer
Heart failure (HF) remains a major cause of mortality and morbidity worldwide.
Understanding the genetic basis of HF allows for the development of disease-modifying …